134 related articles for article (PubMed ID: 37173417)
21. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
22. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of clinical efficacy between HLA-mismatched related and HLA-matched unrelated donor hematopoietic stem cell transplantation for hematopoietic malignancies].
Yu S; Dai M; Sun J; Fan Z; Huang F; Zhang Y; Jiang Q; Zhou H; Xu D; Meng F; Liu Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):826-30. PubMed ID: 25246252
[TBL] [Abstract][Full Text] [Related]
24. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
25. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
26. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
[TBL] [Abstract][Full Text] [Related]
27. Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia.
Cancio M; Hebert K; Kim S; Aljurf M; Olson T; Anderson E; Burroughs L; Vatsayan A; Myers K; Hashem H; Hanna R; Horn B; Prestidge T; Boelens JJ; Boulad F; Eapen M
Transplant Cell Ther; 2022 Feb; 28(2):101.e1-101.e6. PubMed ID: 34670170
[TBL] [Abstract][Full Text] [Related]
28. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
[TBL] [Abstract][Full Text] [Related]
29. Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Martínez C; Gayoso J; Canals C; Finel H; Peggs K; Dominietto A; Castagna L; Afanasyev B; Robinson S; Blaise D; Corradini P; Itälä-Remes M; Bermúdez A; Forcade E; Russo D; Potter M; McQuaker G; Yakoub-Agha I; Scheid C; Bloor A; Montoto S; Dreger P; Sureda A;
J Clin Oncol; 2017 Oct; 35(30):3425-3432. PubMed ID: 28846465
[TBL] [Abstract][Full Text] [Related]
30. Cord-Blood Transplantation in Patients with Minimal Residual Disease.
Milano F; Gooley T; Wood B; Woolfrey A; Flowers ME; Doney K; Witherspoon R; Mielcarek M; Deeg JH; Sorror M; Dahlberg A; Sandmaier BM; Salit R; Petersdorf E; Appelbaum FR; Delaney C
N Engl J Med; 2016 Sep; 375(10):944-53. PubMed ID: 27602666
[TBL] [Abstract][Full Text] [Related]
31. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
Canaani J; Savani BN; Labopin M; Michallet M; Craddock C; Socié G; Volin L; Maertens JA; Crawley C; Blaise D; Ljungman PT; Cornelissen J; Russell N; Baron F; Gorin N; Esteve J; Ciceri F; Schmid C; Giebel S; Mohty M; Nagler A
Am J Hematol; 2017 Aug; 92(8):789-796. PubMed ID: 28439910
[TBL] [Abstract][Full Text] [Related]
32. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
Ciurea SO; Saliba RM; Rondon G; Patah PA; Aung F; Cano P; Andersson BS; Kebriaei P; Popat U; Fernandez-Vina M; Champlin RE; de Lima M
Biol Blood Marrow Transplant; 2011 Jun; 17(6):923-9. PubMed ID: 20969970
[TBL] [Abstract][Full Text] [Related]
34. Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Nagler A; Labopin M; Dholaria B; Blaise D; Bondarenko S; Vydra J; Choi G; Rovira M; Reményi P; Meijer E; Bulabois CE; Diez-Martin JL; Yakoub-Agha I; Brissot E; Spyridonidis A; Sanz J; Patel A; Arat M; Bazarbachi A; Bug G; Savani BN; Giebel S; Ciceri F; Mohty M
Br J Haematol; 2023 Jun; 201(6):1169-1178. PubMed ID: 36949658
[TBL] [Abstract][Full Text] [Related]
35. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
[TBL] [Abstract][Full Text] [Related]
36. Human leukocyte antigen 7/8-matched unrelated bone marrow transplantation using anti-thymocyte globulin in children.
Hamada M; Muramatsu H; Torii Y; Suzuki K; Narita A; Yoshida T; Imaya M; Yamamori A; Wakamatsu M; Miwata S; Narita K; Kataoka S; Kawashima N; Taniguchi R; Nishikawa E; Nishio N; Ito Y; Kojima S; Takahashi Y
Int J Hematol; 2023 Jul; 118(1):125-130. PubMed ID: 36881377
[TBL] [Abstract][Full Text] [Related]
37. Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
Konuma T; Kanda J; Uchida N; Nishijima A; Tanaka M; Ozawa Y; Sawa M; Onizuka M; Ota S; Maruyama Y; Kanda Y; Kawakita T; Ara T; Eto T; Nakamae H; Kimura T; Fukuda T; Atsuta Y;
Hematol Oncol; 2023 Feb; 41(1):147-158. PubMed ID: 36268564
[TBL] [Abstract][Full Text] [Related]
38. Disability related to chronic graft -
Fatobene G; Storer BE; Salit RB; Lee SJ; Martin PJ; Cheng GS; Carpenter PA; Balgansuren G; Petersdorf EW; Delaney C; Sandmaier BM; Milano F; Flowers ME
Haematologica; 2019 Apr; 104(4):835-843. PubMed ID: 30442722
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.
Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352
[TBL] [Abstract][Full Text] [Related]
40. Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
Perales MA; Tomlinson B; Zhang MJ; St Martin A; Beitinjaneh A; Gibson J; Hogan W; Kekre N; Lazarus H; Marks D; McGuirk J; Romee R; Solh M; Wagner JE; Weisdorf DJ; de Lima M; Eapen M
Haematologica; 2020; 105(2):407-413. PubMed ID: 31101756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
